Atai Life Sciences Gross Profit 2020-2024 | ATAI

Atai Life Sciences gross profit from 2020 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Atai Life Sciences Annual Gross Profit
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $20
2020 $0
2019 $0
Atai Life Sciences Quarterly Gross Profit
(Millions of US $)
2024-12-31 $0
2024-09-30 $0
2024-06-30 $0
2024-03-31
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
2022-09-30 $0
2022-06-30 $0
2022-03-31
2021-12-31 $0
2021-09-30 $0
2021-06-30
2021-03-31 $20
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.278B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.755B 19.47
Encompass Health (EHC) United States $11.734B 24.87
DaVita (DVA) United States $11.050B 14.67
Chemed (CHE) United States $8.342B 26.22
Elanco Animal Health (ELAN) United States $5.940B 12.72
Option Care Health (OPCH) United States $5.214B 23.24
RadNet (RDNT) United States $4.181B 88.48
Amedisys (AMED) United States $3.128B 21.04
LifeStance Health (LFST) United States $2.228B 0.00
Addus HomeCare (ADUS) United States $2.041B 22.41
Astrana Health (ASTH) United States $1.666B 41.26
U.S Physical Therapy (USPH) United States $1.125B 29.05
Aveanna Healthcare Holdings (AVAH) United States $1.054B 60.00
Pennant (PNTG) United States $0.985B 36.18
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00